Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor.
Nerou EP
,
Riley AM
,
Potter BV
,
Taylor CW
.
???displayArticle.abstract???
Synthetic analogues of inositol trisphosphate (IP(3)), all of which included structures equivalent to the 4,5-bisphosphate of (1,4,5)IP(3), were used to probe the recognition properties of rat full-length type 1, 2 and 3 IP(3) receptors expressed in insect Spodoptera frugiperda 9 cells. Using equilibrium competition binding with [(3)H](1,4,5)IP(3) in Ca(2+)-free cytosol-like medium, the relative affinities of the receptor subtypes for (1,4,5)IP(3) were type 3 (K(d)=11+/-2 nM)>type 2 (K(d)=17+/-2 nM)>type 1 (K(d)=24+/-4 nM). (1,4,5)IP(3) binding was reversibly stimulated by increased pH, but the subtypes differed in their sensitivity to pH (type 1>type 2>type 3). For all three subtypes, the equatorial 6-hydroxy group of (1,4,5)IP(3) was essential for high-affinity binding, the equatorial 3-hydroxy group significantly improved affinity, and the axial 2-hydroxy group was insignificant; a 1-phosphate (or in its absence, a 2-phosphate) improved binding affinity. The subtypes differed in the extents to which they tolerated inversion of the 3-hydroxy group of (1,4,5)IP(3) (type 1>type 2>type 3), and this probably accounts for the selectivity of (1,4,6)IP(3) for type 1 receptors. They also differed in their tolerance of inversion, removal or substitution (by phosphate) of the 2-hydroxy group (types 2 and 3>type 1), hence the selectivity of (1,2,4,5)IP(4) for type 2 and 3 receptors. Removal of the 3-hydroxy group or its replacement by fluorine or CH(2)OH was best tolerated by type 3 receptors, and accounts for the selectivity of 3-deoxy(1,4,5)IP(3) for type 3 receptors. Our results provide the first systematic analysis of the recognition properties of IP(3) receptor subtypes and have identified the 2- and 3-positions of (1,4,5)IP(3) as key determinants of subtype selectivity.
Blondel,
Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues.
1993, Pubmed
Blondel,
Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues.
1993,
Pubmed
Boulay,
Modulation of Ca(2+) entry by polypeptides of the inositol 1,4, 5-trisphosphate receptor (IP3R) that bind transient receptor potential (TRP): evidence for roles of TRP and IP3R in store depletion-activated Ca(2+) entry.
1999,
Pubmed
Cardy,
Differential regulation of types-1 and -3 inositol trisphosphate receptors by cytosolic Ca2+.
1997,
Pubmed
Cardy,
A novel role for calmodulin: Ca2+-independent inhibition of type-1 inositol trisphosphate receptors.
1998,
Pubmed
De Smet,
The relative order of IP3 sensitivity of types 1 and 3 IP3 receptors is pH dependent.
1999,
Pubmed
DeLisle,
Expression of inositol 1,4,5-trisphosphate receptors changes the Ca2+ signal of Xenopus oocytes.
1996,
Pubmed
,
Xenbase
DeLisle,
Second messenger specificity of the inositol trisphosphate receptor: reappraisal based on novel inositol phosphates.
1994,
Pubmed
,
Xenbase
Hagar,
Type III InsP3 receptor channel stays open in the presence of increased calcium.
1998,
Pubmed
Hirata,
Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
1993,
Pubmed
Hirata,
Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate.
1997,
Pubmed
Hirata,
Synthetic inositol trisphosphate analogs and their effects on phosphatase, kinase, and the release of Ca2+.
1989,
Pubmed
Hirata,
Stereospecific recognition of inositol 1,4,5-trisphosphate analogs by the phosphatase, kinase, and binding proteins.
1990,
Pubmed
Inoue,
Type 1 inositol 1,4,5-trisphosphate receptor is required for induction of long-term depression in cerebellar Purkinje neurons.
1998,
Pubmed
Khan,
Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor.
1996,
Pubmed
Lu,
Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
1994,
Pubmed
Marchant,
Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
1997,
Pubmed
Mignery,
Structure and expression of the rat inositol 1,4,5-trisphosphate receptor.
1990,
Pubmed
Mills,
Synthesis of D- and L-myo-Inositol 1,4,6-Trisphosphate, Regioisomers of a Ubiquitous Second Messenger.
1996,
Pubmed
Miyakawa,
Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes.
1999,
Pubmed
Newton,
Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3.
1994,
Pubmed
Patel,
Molecular properties of inositol 1,4,5-trisphosphate receptors.
1999,
Pubmed
Polokoff,
Metabolism of synthetic inositol trisphosphate analogs.
1988,
Pubmed
Riley,
Unambiguous total synthesis of the enantiomers of myo-inositol 1,3,4-trisphosphate: 1L-myo-inositol 1,3,4-trisphosphate mobilizes intracellular Ca2+ in Limulus photoreceptors.
1994,
Pubmed
Safrany,
3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition.
1992,
Pubmed
Safrany,
Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
1991,
Pubmed
Sugawara,
Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor.
1997,
Pubmed
Swatton,
Type 3 inositol trisphosphate receptors in RINm5F cells are biphasically regulated by cytosolic Ca2+ and mediate quantal Ca2+ mobilization.
1999,
Pubmed
Südhof,
Structure of a novel InsP3 receptor.
1991,
Pubmed
Taylor,
Expression of inositol trisphosphate receptors.
1999,
Pubmed
Vanlingen,
Ca2+ and calmodulin differentially modulate myo-inositol 1,4, 5-trisphosphate (IP3)-binding to the recombinant ligand-binding domains of the various IP3 receptor isoforms.
2000,
Pubmed
Vanlingen,
Modulation of type 1, 2 and 3 inositol 1,4,5-trisphosphate receptors by cyclic ADP-ribose and thimerosal.
1999,
Pubmed
Varney,
Are there subtypes of the inositol 1,4,5-trisphosphate receptor?
1990,
Pubmed
Wilcox,
Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
1994,
Pubmed
Wilcox,
Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
1994,
Pubmed
Wilcox,
New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor.
1998,
Pubmed
Wojcikiewicz,
Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types.
1995,
Pubmed
Wojcikiewicz,
Differences among type I, II, and III inositol-1,4,5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1,4,5-trisphosphate.
1998,
Pubmed
Yoneshima,
Ca2+ differentially regulates the ligand-affinity states of type 1 and type 3 inositol 1,4,5-trisphosphate receptors.
1997,
Pubmed
